Latest news and articles about obesity drugs from NEX English
India is witnessing a significant rise in cheap copies of the drug 'semaglutide', negatively affecting sales for Eli Lilly. This situation raises questions about the company's future as patent expirations approach.
Reports indicate that Nirokrin is nearing a deal to acquire Soleno Therapeutics, potentially enhancing its efforts to develop new obesity treatments. This announcement comes amid significant changes in the pharmaceutical market.
Innovent Biologics has announced its first-ever profits, showcasing the success of its strategies in the obesity drug market. This comes as the company faces increasing competition from generic weight loss medications in China.
Kailera Therapeutics has announced its application for an initial public offering (IPO) in the United States to raise funds for developing a range of obesity treatments. This move comes as the global demand for effective solutions to combat the obesity crisis continues to rise.